Metraipolis › archive › dc_ce21abef4d26

Beyond the Virological Benefits of the Herpes Zoster Vaccine in the Context of Primary Care — Europe PMC PMID:41600995

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41600995
DOI
10.3390/vaccines14010079
License (as archived)
solo-consultazione
Archived
2026-11-06T22:05:08.886Z
SHA-256 of the archived text
63c8b582cd9184fc6ff43b72f65298aacbc685d7745f356ad12e204605416080
Stable URL of this page
https://metraipolis.com/documento/dc_ce21abef4d26

How to cite

Beyond the Virological Benefits of the Herpes Zoster Vaccine in the Context of Primary Care — Europe PMC PMID:41600995 — Europe PMC (en), https://europepmc.org/article/MED/41600995 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ce21abef4d26 (Metraipolis archive dc_ce21abef4d26, sha256 63c8b582cd9184fc6ff43b72f65298aacbc685d7745f356ad12e204605416080)
BibTeX
@misc{dcce21abef4d26,
  title = {Beyond the Virological Benefits of the Herpes Zoster Vaccine in the Context of Primary Care — Europe PMC PMID:41600995},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41600995},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ce21abef4d26; sha256 63c8b582cd9184fc6ff43b72f65298aacbc685d7745f356ad12e204605416080},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41600995. Agents can read the archived copy with the MCP tool read_document.